![]() |
Emotional Processing |
|||||||||||||||||||||||||||
|
Emotion concepts: alexithymia |
||||||||||||||||||||||||||||
'But
what am I?
Alfred,
Lord Tennyson |
Alexithymia
(literally; no words for emotion) The
alexithymia concept derived from clinical observations that psychosomatic
patients were unimaginative and showed difficulties with the verbal and
symbolic expression of emotion (Ruesch, 1948). Later, empirical studies
demonstrated this phenomenon. For example, Sifneos (1973) found that
psychosomatic patients tended to have a relative constriction in emotional
functioning, a poverty of fantasy, and an inability to find appropriate
words to describe emotions. Psychosomatic patients possessed twice as many
alexithymic characteristics when compared to controls. Recently,
Sifneos expanded on the concept, “Alexithymia, a term I introduced
for better or worse in 1972, involves a marked difficulty to use
appropriate language to express and describe feelings and to differentiate
them from bodily sensations, a striking paucity of fantasies and a
utilitarian way of thinking which Marty et al [1963] have called penseé
opératoire” (Sifneos, 2000). According
to
Taylor, Doddy & Newman 1981 ‘alexithymia’ refers to a hypothetical personality
construct that is characterised by, “(1) a difficulty in identifying
and communicating feelings, (2) a difficulty in distinguishing between
feelings and bodily sensations (3) impaired symbolization, as evidenced by
paucity of fantasies and other imaginative activity, and (4) a preference
for focussing on external events rather than inner experiences.”
(Taylor & Bagby 1988, p.352). As
a reflection of the increasing interest in this construct, alexithymia was
chosen as the main theme of the 11th European Conference on
Psychosomatic Research at Heidelberg, in 1976 (Brautigam & Von Rad,
1977). Indeed, Taylor in 2000 comments that, “While about 120
articles were published on alexithymia by the mid-1980s, a recent search
of the PsycInfo database revealed well over 700 journal articles on
alexithymia.” (Taylor, 2000, p.134.). How
is it measured? The
Beth Israel Hospital Psychosomatic Questionnaire (BIQ) This
measure of alexithymia is a 17-item forced choice questionnaire that was
developed by Sifneos to measure psychosomatic diseases. The items are
completed by the interviewer after a structured interview with the
patient. Eight of the items here are thought to be directly related to the
alexithymia construct, and therefore only these 8 items are used in
obtaining an alexithymia score. A cut-off score, arbitrarily chosen, of 6
yields an alexithymic (≥6) and non-alexithymic (<6)
categorisation. There have,
however, been a number of methodological criticisms of this scale. The
forced choice nature of this scale (true, false) may be unsatisfactory as
dichotomous scales can be unstable in factor analyses (Taylor & Bagby,
1988). Perhaps the most pertinent criticisms levelled at the BIQ are that
it is time-consuming, and subject to experimenter or observer bias (Kleiger
& Kinsman, 1980; Lolas, De La Parra, Arohnson & Colin 1980; Taylor,
Doddy & Newman 1981). Schalling-Sifneos
Personality Scale (SSPS) This self-report scale has 20 items and uses a 4-point Likert scale. Lower scores indicate increased levels of alexithymia. Sifneos suggests that a score of 50 or below indicates alexithymia. Unfortunately, this test was not subjected to item analysis during its construction, leaving it psychometrically weak. Other studies have found that its internal consistency is unsatisfactory (Bagby, Taylor & Ryan 1986; Bagby, Taylor & Atkinson 1988; Faryna, Rodenhauser & Torem 1986). Parker, Taylor & Bagby (1991) have strongly criticised a revised version of the SPSS (Sifneos, 1986) on psychometric grounds, and Bagby, Taylor & Atkinson (1988) advise against its further use. The
MMPI (Welsh & Dahlstrom, 1963; Good & Brantner, 1974) is a
psychometric instrument that has been used to assess personality traits in
a variety of medical and psychiatric syndromes. It contains 566
dichotomous choice (true or false) items that relate to mood, behaviour,
self-concept and personal preferences. An alexithymia scale on the MMPI
was developed (Kleiger & Kinsman, 1980) in response to a finding that
the MMPI did not distinguish between alexithymic and non-alexithymic
groups as measured by the BIQ (Kleiger & Jones, 1979). As Parker et al
(1991) have pointed out, the alexithymia scale on the MMPI has been
criticised for a lack of internal consistency, having a social
desirability bias, and not relating well to other constructs. As with the
SSPS, Bagby et al (1988) advise against future use of the MMPI-A. The Toronto Alexithymia Scale (TAS) The
TAS was constructed after a literature review revealed 5 main content
areas thought to reflect the construct. Forty-one items were devised based
on the content areas. From these 41 items, 15 were deleted for failing to
meet 2 statistical criteria. This left 26 items from which a factor
analysis suggested a four-factor solution. Factor I consisted of items
that refer to the ability to identify and describe feelings and to
distinguish between bodily sensations, factor II reflected the ability to
communicate feelings to others,
factor III represented the ability to daydream, and IV represented the
tendency to focus on external events over inner experiences. The TAS uses
a 5-point Likert type rating scale from 1 (strongly disagree) to 5
(strongly agree). The TAS has shown adequate internal consistency, good
test-retest reliability, and good convergent and discriminant validity
(Taylor et al, 1997). However, there are some limitations to the TAS. The
‘day dreaming’ factor has been shown to correlate negatively with
alexithymia and has been partly explained by a social desirability
response bias. There have also been high correlations between factors I
and II and very low correlations between factors III and IV (Taylor et al,
1997). In response to these weaknesses and in recognising that scale
development is an ongoing process, further revisions were made. The
Twenty Item Toronto Alexithymia Scale (TAS-20) After
a revised edition to the TAS, a twenty-item version was devised. The
TAS-20 has 3 factors including: difficulty identifying feelings and
distinguishing them from bodily sensations (F1), difficulty describing
feelings to others (F2), and externally oriented thinking (F3).
Preliminary evidence of reliability and factorial validity has been
established (Bagby, Parker & Taylor, 1994-II). The TAS and TAS-20 are now the most
widely used measures of alexithymia (Taylor, 2000). Relationship with somatic illness It
is proposed that the limited emotional awareness and cognitive processing
of affect seen in alexithymia, leads to individuals focussing on and
amplifying the somatic aspect of emotional. This may explain the apparent
association between alexithymia and psychiatric disorders with somatic
presentations and even somatic illness. Alexithymia has been associated
with hypertension (Todarello, Taylor, Parker & Fanalli 1995), inflammatory bowel disease (Porcelli,
Zaka, Leoci, Centonze, Taylor & Parker 1995), functional gastrointestinal disorders (Porcelli et al,
1999), somatoform disorders (Cox, Kuch, Parker, Shulman & Evans 1994), panic disorder (Zeitlin
& McNally, 1993) and eating disorders (De Groot, Rodin & Olmstead, 1995). Emotional processing and alexithymia In
summary, alexithymia is a hypothetical personality construct that involves
impairments in identifying feelings and describing feelings, a paucity of
fantasy life, and a tendency towards externally oriented thinking. How
then, does alexithymia relate to emotional processing? A
recent empirical study outlining the psychometric properties of a new
emotional processing scale (EPS) showed that alexithymia is related to
emotional processing (Baker, Thomas, Owens & Thomas 2003 in preparation). Correlations
between the TAS-20 subscales and the EPS total score are quite high
(identifying feelings r=0.69, describing feelings r=0.67, and the total
TAS-20 r=0.71). The externally oriented thinking subscale produced a more
moderate correlation with total EPS (r=0.30). This suggests that there is
some relationship between the two constructs (approximately, a 50%
overlap). Intuitively, this seems to make sense as the two constructs
pertain to both emotions and to cognitive-emotional processes. Exploring
the data of the study further, there were low correlations between the
TAS-20 total score and some of the EPS subscales. For example, on the
intrusive and persistent thoughts subscale (r=0.22), the can’t control
subscale (r=0.36), and the avoidance subscale (r=0.39). It would appear
that these subscales of the EPS are measuring dimensions other than
alexithymia. Emotional
processing was designed as broader in scope than alexithymia. It was meant
to apply particularly to patients with psychological problems, physical
illness and psychosomatic conditions, as well as healthy or 'normal'
states of mind. Its aim is to capture the
various processes at work in emotional processing at psychological,
psychoneurological and physiological levels, rather than refer to a
personality trait, a type of individual or a diagnostic condition or
category. In emotional processing a range of different deficits are
conceivable, for instance patients with anxiety disorders may show a
different pattern of emotional processing to those with depression. Alexithymia is concerned with one trait or category, rather like a
diagnosis. Its roots are psychoanalytic and medical; the emotional
processing model is more closely related to the concepts of clinical
psychology. Alexithymia network: http://alexithymia.med.up.pt/public/docs/rightframe_files/books-body.htm
|
|||||||||||||||||||||||||||
|
Dorset
RDSU |
||||||||||||||||||||||||||||
© Dorset RDSU 2003